Intranasal Delivery of Nerve Growth Factor in Neurodegenerative Diseases and Neurotrauma

Overview of attention for article published in Frontiers in Pharmacology, November 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 1 news outlet
twitter: 2 X users

patent: 2 patents

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 30 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

INTRANASAL ADMINISTRATION OF NGF FOR THE TREATMENT OF SENSORINEURAL HEARING LOSS

Application WO-2024028487-A1

World Intellectual Property Organisation (WIPO)

INTRANASAL ADMINISTRATION OF NGF FOR THE TREATMENT OF SENSORINEURAL HEARING LOSS

Application EP-4316505-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.